Global Synthetic Blood Substitutes and Blood Product Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Synthetic Blood Substitutes and Blood Product Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Artificial blood replacement in the human body is referred to as synthetic blood substitutes. A blood replacement is a substance that is utilised to meet the biological needs of the body that are not met by real blood. A set of chemicals made consisting of carbon and fluorine are used to create artificial blood. These molecules may dissolve 50 times more oxygen into the body than blood plasma. Internally, the molecules work similarly to blood, supplying oxygen to different regions of the body, organs, and tissues.Patients suffer massive blood loss as a result of catastrophic injuries and diseases, resulting in the deaths of thousands of patients each year. Fresh blood also has a 42-hour life span. Because of this obstacle, synthetic blood substitutes are required to meet the patient's immediate blood supply needs and to extend his or her life.
Synthetic Blood Substitutes and Blood Product report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Synthetic Blood Substitutes and Blood Product market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Hospitals and Clinics and Blood Banks are the major drivers for the industry.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Synthetic Blood Substitutes and Blood Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Aurum Biosciences Ltd
Hemarina SA
KaloCyte Inc.
NuvOx Pharma LLC
Northfield Laboratories
Dentritech, Inc.
HemoBioTech, Inc.
Dextro-Sang Corp.
Baxter International
FluorO2 Therapeutics
Alpha Therapeutic Corp.
Hemoglobin Oxygen Therapeutics LLC
SpheriTech Ltd
Sangart, Inc.
BioPure
PHORNANO Holding GmbH
Segment by Type
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others
Hospitals and Clinics
Blood Banks
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Synthetic Blood Substitutes and Blood Product market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Synthetic Blood Substitutes and Blood Product, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Synthetic Blood Substitutes and Blood Product industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Synthetic Blood Substitutes and Blood Product in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Synthetic Blood Substitutes and Blood Product introduction, etc. Synthetic Blood Substitutes and Blood Product Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Synthetic Blood Substitutes and Blood Product market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.![](http://localhost/mraccuracy/images/About Report.webp)
Synthetic Blood Substitutes and Blood Product report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Synthetic Blood Substitutes and Blood Product market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Hospitals and Clinics and Blood Banks are the major drivers for the industry.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Synthetic Blood Substitutes and Blood Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Aurum Biosciences Ltd
Hemarina SA
KaloCyte Inc.
NuvOx Pharma LLC
Northfield Laboratories
Dentritech, Inc.
HemoBioTech, Inc.
Dextro-Sang Corp.
Baxter International
FluorO2 Therapeutics
Alpha Therapeutic Corp.
Hemoglobin Oxygen Therapeutics LLC
SpheriTech Ltd
Sangart, Inc.
BioPure
PHORNANO Holding GmbH
Segment by Type
Human Blood
Animal Blood
Microorganisms
Synthetic Polymers
Stem Cells
Others
Segment by Application
Hospitals and Clinics
Blood Banks
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Synthetic Blood Substitutes and Blood Product market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Synthetic Blood Substitutes and Blood Product, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Synthetic Blood Substitutes and Blood Product industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Synthetic Blood Substitutes and Blood Product in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Synthetic Blood Substitutes and Blood Product introduction, etc. Synthetic Blood Substitutes and Blood Product Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Synthetic Blood Substitutes and Blood Product market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
![](http://localhost/mraccuracy/images/About Report.webp)